Guilford halts Gliatech deal

Article Abstract:

Baltimore, MD-based Guilford Pharmaceuticals scratched plans to acquire Cleveland, OH-based Gliatech. The move was motivated by the FDA's questioning of irregularities in Gliaaatech's clinical trial data of its anti-scarring gel.

Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Drugs, Guilford Pharmaceuticals Inc., GLFD

---

Guilford acquires Gliatech in strategic deal

Article Abstract:

Guildford Pharmaceuticals has reached an agreement to purchase Gliatech, a biotechnology company. Guildford is acquiring Gliatech for approximately $203 million in shares.

Biochemistry, Research and Development in the Physical, Engineering, and Life Sciences, Guildford Pharmaceuticals

---

Monsanto to merge with P&U

Article Abstract:

Article discussing how Monsanto has agreed to merge with Pharmacia and Upjohn (P&U). Monsanto will give up its agricultural unit.

Chemicals & Allied Products, Chemical Manufacturing, CHEMICALS AND ALLIED PRODUCTS, Brief Article, Chemicals, Monsanto Co., Pharmacia and Upjohn Inc., MTC, PNU

Similar abstracts:

• Abstracts: A service effort allocation model for assessing customer lifetime value in service marketing. After-service response in service quality assessment: real time updating model approach
• Abstracts: Life's a switch and then you buy. Be a better investor. Stop-losses, do they work?
• Abstracts: Stocking fillers with a future. Life with the dogs. What's hot?
• Abstracts: Why Footsie isn't listening. UK equities: a tough year. Phone fun
• Abstracts: Trehalose expression confers desiccation tolerance on human cells. Measuring the peptides in individual organelles with mass spectrometry

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.